Canopy Growth Reports First Quarter Fiscal 2026 Financial Results; Cannabis Revenue Increased 24% Year-Over-Year

Stock Information for TriSalus Life Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TriSalus Life Sciences Inc.

Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia
Canopy Growth Appoints Miles Worne as Managing Director of European Markets
Canopy Growth to Strengthen Balance Sheet with Early Prepayments Set to Reduce Term Loan by US$50 Million; Annual Cash Interest Expense Expected to be Reduced by US$6.5 Million
Canopy Growth to Report First Quarter Fiscal 2026 Financial Results on August 8, 2025
Canopy Growth Launches Deep Space Infused Pre-Rolls
Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer
Storz & Bickel Named "Equipment Provider of the Year" at Business of Cannabis Awards 2025
Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.